Geometric relationship between the projected surface area and mass of a plastic particle.

The quantification of the mass of meso/microplastic (MMP) particles is crucial for assessing the global inventory of ocean plastics and assessing environmental and human health risks. Herein, linear regression models between mass and projected surface area on a log scale were established by directly measuring the masses of 4390 MMP particles collected at 35 sites in 17 Japanese rivers with an ultramicrobalance. The linear regression models estimated mass concentrations more accurately than any previous method based on geometric volume assuming several three-dimensional shapes. Additionally, linear regression models were quite reasonable for determining the geometric relationships of idealized cuboid particles. The slope of the linear regression models was dependent on the three-dimensional shapes of the particles, and their intercept was determined according to their third dimension. Moreover, the third dimension led to uncertainty in the mass estimation of particles; thus, the accuracies of the previous methods were relatively poor. Nevertheless, two limitations for mass measurement by linear regression models were identified, which determined the size range of the MMP particles on the projected surface area (ranging from 10-4 mm2 to 102 mm2) that is applicable for mass estimation of the particles collected from riverine and marine environments. Our results could be used to accurately estimate the mass concentrations in aquatic environments and provide insights into the geometric relationships between the mass and size of MMP particles.

The Effects of a Red-Light Controllable Nitric Oxide Donor, NORD-1, on Erectile Dysfunction in Rats with Streptozotocin Induced Diabetes Mellitus.

PURPOSE: Patients with diabetes mellitus (DM) often exhibit refractory erectile dysfunction (ED). Red-light-controllable nitric oxide donor (NORD-1) and red-light irradiation have successfully enhanced erectile function in intact rats. In this study, we investigated whether the combination of NORD-1 and red-light irradiation effectively treated ED in streptozotocin (STZ)-treated rats with DM. MATERIALS AND METHODS: Seven-week-old male Sprague-Dawley rats were used in this study. Rats in the DM and sham groups received intravenous STZ (50 mg/kg) and saline, respectively. One week after treatment, the blood glucose level of rats in the DM group was >250 mg/dL. Five weeks after the treatment, we performed a functional study by measuring intracavernous pressure (ICP) under cavernous nerve stimulation before and after NORD-1 treatment with and without light irradiation. Additionally, we performed an isometric tension study using the corpus cavernosum of rats treated with NORD-1 or the control compound, SiR650. RESULTS: The ICP/mean arterial pressure (MAP) ratio was significantly lower in the DM group than in the sham group before and after NORD-1 treatment without light irradiation (both p<0.05). After NORD-1 treatment with light irradiation, the ICP/MAP ratio in the sham and DM groups was significantly enhanced than before and after NORD-1 treatment without light irradiation (all p<0.05). The ICP/MAP ratio in the DM group after NORD-1 with light irradiation was similar to that in the sham group under normal conditions before NORD-1 treatment. Moreover, the systemic blood pressure was not affected by NORD-1 or light irradiation. In the tension study, the corpus cavernosum of rats treated with SiR650 was not changed by red light in the sham or DM groups. However, the rats treated with NORD-1 were strongly relaxed by red light in both groups. CONCLUSIONS: NORD-1 and red-light irradiation could improve ED in the presence of DM without lowering blood pressure.